fda compounding semaglutide crackdown news today 2025 The is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA enforcement Hims to stop offering GLP-1

Colorectal cancer prevention has traditionally rested on three pillars: population screening, lifestyle modification, and selective chemoprevention

And the solution should still be clear , meaning you can see through it even though it has color

Lindsay Lindsay gained 43 pounds in about 6 months while her PCP kept telling her labs were fine

Specifically, improvement of overall CV outcomes was likely driven by reduction in HF-related events in trials investigating SGLT2 inhibitors, and by reduction in atherosclerotic events in those investigating GLP-1RAs

For many patients, this can lead to: Loose or sagging skin Hollow cheeks or temples Increased fine lines and wrinkles Crepey skin texture Loss of facial definition Deflated appearance in areas like the breasts or buttocks These changes are not caused by the medication itself as much as they are the result of rapid weight loss

Frequently Asked Questions Prohibited List Click on the question to drop down the answer